312 related articles for article (PubMed ID: 17709330)
1. Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.
Shaw PJ; Hopfensperger MJ; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):259-66. PubMed ID: 17709330
[TBL] [Abstract][Full Text] [Related]
2. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
Tukov FF; Luyendyk JP; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.
Shaw PJ; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2009 Jan; 328(1):62-8. PubMed ID: 18820134
[TBL] [Abstract][Full Text] [Related]
4. Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury.
Shaw PJ; Ditewig AC; Waring JF; Liguori MJ; Blomme EA; Ganey PE; Roth RA
Toxicol Sci; 2009 Jan; 107(1):270-80. PubMed ID: 18930950
[TBL] [Abstract][Full Text] [Related]
5. The role of the hemostatic system in murine liver injury induced by coexposure to lipopolysaccharide and trovafloxacin, a drug with idiosyncratic liability.
Shaw PJ; Fullerton AM; Scott MA; Ganey PE; Roth RA
Toxicol Appl Pharmacol; 2009 May; 236(3):293-300. PubMed ID: 19367693
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils.
Waring JF; Liguori MJ; Luyendyk JP; Maddox JF; Ganey PE; Stachlewitz RF; North C; Blomme EA; Roth RA
J Pharmacol Exp Ther; 2006 Mar; 316(3):1080-7. PubMed ID: 16299187
[TBL] [Abstract][Full Text] [Related]
7. Tissue influx of neutrophils and monocytes is delayed during development of trovafloxacin-induced tumor necrosis factor-dependent liver injury in mice.
Giustarini G; Kruijssen L; van Roest M; Bleumink R; Weaver RJ; Bol-Schoenmakers M; Smit J; Pieters R
J Appl Toxicol; 2018 May; 38(5):753-765. PubMed ID: 29377180
[TBL] [Abstract][Full Text] [Related]
8. Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity.
Shaw PJ; Beggs KM; Sparkenbaugh EM; Dugan CM; Ganey PE; Roth RA
Toxicol Sci; 2009 Oct; 111(2):288-301. PubMed ID: 19638433
[TBL] [Abstract][Full Text] [Related]
9. Trovafloxacin enhances the inflammatory response to a Gram-negative or a Gram-positive bacterial stimulus, resulting in neutrophil-dependent liver injury in mice.
Shaw PJ; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2009 Jul; 330(1):72-8. PubMed ID: 19351866
[TBL] [Abstract][Full Text] [Related]
10. Comparison of TNFα to lipopolysaccharide as an inflammagen to characterize the idiosyncratic hepatotoxicity potential of drugs: Trovafloxacin as an example.
Liguori MJ; Ditewig AC; Maddox JF; Luyendyk JP; Lehman-McKeeman LD; Nelson DM; Bhaskaran VM; Waring JF; Ganey PE; Roth RA; Blomme EA
Int J Mol Sci; 2010 Nov; 11(11):4697-714. PubMed ID: 21151465
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone exposure during modest inflammation induces idiosyncrasy-like liver injury in rats: role of tumor necrosis factor-alpha.
Lu J; Jones AD; Harkema JR; Roth RA; Ganey PE
Toxicol Sci; 2012 Jan; 125(1):126-33. PubMed ID: 21984482
[TBL] [Abstract][Full Text] [Related]
12. Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase.
Poulsen KL; Albee RP; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2014 May; 349(2):185-91. PubMed ID: 24525298
[TBL] [Abstract][Full Text] [Related]
13. Trovafloxacin-induced replication stress sensitizes HepG2 cells to tumor necrosis factor-alpha-induced cytotoxicity mediated by extracellular signal-regulated kinase and ataxia telangiectasia and Rad3-related.
Beggs KM; Maiuri AR; Fullerton AM; Poulsen KL; Breier AB; Ganey PE; Roth RA
Toxicology; 2015 May; 331():35-46. PubMed ID: 25748550
[TBL] [Abstract][Full Text] [Related]
14. The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro.
Giustarini G; Huppelschoten S; Barra M; Oppelt A; Wagenaar L; Weaver RJ; Bol-Schoenmakers M; Smit JJ; van de Water B; Klingmüller U; Pieters RHH
Toxicol Appl Pharmacol; 2020 Mar; 391():114915. PubMed ID: 32035082
[TBL] [Abstract][Full Text] [Related]
15. Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury.
Kuhla A; Eipel C; Abshagen K; Siebert N; Menger MD; Vollmar B
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1069-76. PubMed ID: 19264954
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction.
Beggs KM; Fullerton AM; Miyakawa K; Ganey PE; Roth RA
Toxicol Sci; 2014 Jan; 137(1):91-101. PubMed ID: 24097668
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline attenuates bacterial lipopolysaccharide-induced enhancement of allyl alcohol hepatotoxicity.
Sneed RA; Buchweitz JP; Jean PA; Ganey PE
Toxicol Sci; 2000 Jul; 56(1):203-10. PubMed ID: 10869469
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice.
He Q; Sharma RP
Toxicon; 2005 Sep; 46(4):404-13. PubMed ID: 16054185
[TBL] [Abstract][Full Text] [Related]
19. Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation.
Deng X; Stachlewitz RF; Liguori MJ; Blomme EA; Waring JF; Luyendyk JP; Maddox JF; Ganey PE; Roth RA
J Pharmacol Exp Ther; 2006 Dec; 319(3):1191-9. PubMed ID: 16990511
[TBL] [Abstract][Full Text] [Related]
20. Ranitidine treatment during a modest inflammatory response precipitates idiosyncrasy-like liver injury in rats.
Luyendyk JP; Maddox JF; Cosma GN; Ganey PE; Cockerell GL; Roth RA
J Pharmacol Exp Ther; 2003 Oct; 307(1):9-16. PubMed ID: 12893837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
